Topical NO + Placebo
Phase 2Completed 0 watching 0 views this week⚡ Active
52
Development Stage
✓
Pre-clinical✓
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Anogenital Warts
Conditions
Anogenital Warts, Condylomata Acuminata
Trial Timeline
Sep 1, 2001 → May 1, 2003
NCT ID
NCT02015260About Topical NO + Placebo
Topical NO + Placebo is a phase 2 stage product being developed by Kyowa Kirin for Anogenital Warts. The current trial status is completed. This product is registered under clinical trial identifier NCT02015260. Target conditions include Anogenital Warts, Condylomata Acuminata.
Hype Score Breakdown
Clinical
17
Activity
12
Company
10
Novelty
5
Community
5
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT02015260 | Phase 2 | Completed |
Competing Products
3 competing products in Anogenital Warts
| Product | Company | Stage | Hype Score |
|---|---|---|---|
| V501 | Merck | Phase 3 | 77 |
| V501 + Placebo | Merck | Phase 3 | 77 |
| AP611074 + Placebo | Vaxart | Phase 1/2 | 33 |